37 results
Page 2 of 2
8-K
EX-99.1
1qdyyix1ewhnccnig
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
S-3/A
po4sx
29 Aug 23
Shelf registration (amended)
4:15pm
S-3
1s6b8pr7x9t9a10ji
22 Aug 23
Shelf registration
4:15pm
424B4
r535ckfq6ea1p9
25 Apr 23
Prospectus supplement with pricing info
4:15pm
10-K
fct3m4xs
31 Mar 23
Annual report
4:17pm
8-K
EX-99.1
8t42w 0vt0ozt28m2s
20 Dec 22
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company’s Innovative Syringe Products
8:20am
8-K
EX-99.1
c47vjt0x
13 Dec 22
Sharps Technology and Nephron Pharmaceuticals Signs Distribution
8:45am
8-K
EX-99.1
kz8b lqoovltoltmvn9
10 Nov 22
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce
4:06pm
8-K
EX-99.1
g8b7vhp nbuct6
14 Jul 22
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility
4:05pm
8-K
EX-99.1
r6d0p8
8 Jun 22
Sharps Technology Announces Letter to Shareholders
4:10pm
424B4
9d9rzbc278kgqkral3
15 Apr 22
Prospectus supplement with pricing info
4:48pm
S-1/A
bce3gyfo644xjp
30 Mar 22
IPO registration (amended)
11:32am
S-1
f5956cvm7
18 Mar 22
IPO registration
5:23pm
DRS/A
i7ap5j
21 Jan 22
Draft registration statement (amended)
12:00am
DRS
diesh6
3 Dec 21
Draft registration statement
12:00am